No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Apriso is a type of gastrointestinal drug used to treat ulcerative colitis, a chronic inflammatory bowel disease. It is a mesalamine-based medication that works by reducing inflammation in the colon. Apriso is taken orally, usually once daily, and is available in both capsule and extended-release tablet form. It is typically used in combination with other medications to treat ulcerative colitis.
Apriso is a relatively new drug, having been approved by the U.S. Food and Drug Administration in 2008. It is marketed by Salix Pharmaceuticals, a subsidiary of Valeant Pharmaceuticals. Other companies that produce similar medications include Allergan, AstraZeneca, and Pfizer. Show Less Read more
